Gerald Schwank was a graduate student in Konrad Basler’s lab at the University of Zurich, where he obtained his Ph.D. in 2009. As a postdoctoral fellow he joined the team of Hans Clevers at the Hubrecht Institute, where he established genome editing approaches in adult stem cell systems. Soon after, he started his own lab at ETH Zurich. While initially his team was dedicated to the establishment of genetic tools to study human disease mechanisms in stem cells and organoids, more recently they have focused on the development of in vivo genome editing approaches to cure monogenic diseases. In 2020 the Schwank lab has moved to the University of Zurich, where they continue to pursue their goal of generating novel genome editors and translating these technologies from bench to bedside.